Patrys Limited (PAB.AX)

AUD 0.0

(0.0%)

Operating Income Summary of Patrys Limited

  • Patrys Limited's latest annual operating income in 2024 was -3.53 Million AUD , up 64.11% from previous year.
  • Patrys Limited's latest quarterly operating income in 2024 FY was -4.92 Million AUD , up 50.1% from previous quarter.
  • Patrys Limited reported an annual operating income of -9.86 Million AUD in 2023, up 13.31% from previous year.
  • Patrys Limited reported an annual operating income of -11.37 Million AUD in 2022, down -94.16% from previous year.
  • Patrys Limited reported a quarterly operating income of -4.92 Million AUD for 2024 FY, up 50.1% from previous quarter.
  • Patrys Limited reported a quarterly operating income of -1.58 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual Operating Income Chart of Patrys Limited (2024 - 2007)

Historical Annual Operating Income of Patrys Limited (2024 - 2007)

Year Operating Income Operating Income Growth
2024 -3.53 Million AUD 64.11%
2023 -9.86 Million AUD 13.31%
2022 -11.37 Million AUD -94.16%
2021 -5.85 Million AUD -67.68%
2020 -3.49 Million AUD -2.42%
2019 -3.41 Million AUD -36.6%
2018 -2.49 Million AUD -5.82%
2017 -2.35 Million AUD -37.04%
2016 -1.72 Million AUD 50.57%
2015 -3.48 Million AUD 52.15%
2014 -7.28 Million AUD -36.28%
2013 -5.34 Million AUD 32.78%
2012 -7.94 Million AUD 14.09%
2011 -9.25 Million AUD 8.58%
2010 -10.12 Million AUD 14.96%
2009 -11.9 Million AUD -37.26%
2008 -8.66 Million AUD 0.0%
2007 - AUD 0.0%

Peer Operating Income Comparison of Patrys Limited

Name Operating Income Operating Income Difference
EZZ Life Science Holdings Limited 9.71 Million AUD 136.424%
Anatara Lifesciences Ltd -1.45 Million AUD -142.553%
Zelira Therapeutics Limited -5.93 Million AUD 40.401%
Biome Australia Limited -1.91 Million AUD -84.982%
Orthocell Limited -11.68 Million AUD 69.702%
Imugene Limited -140.93 Million AUD 97.489%
Noxopharm Limited -7.53 Million AUD 53.031%
PYC Therapeutics Limited -38.85 Million AUD 90.892%
Chimeric Therapeutics Limited -12.3 Million AUD 71.249%
Prescient Therapeutics Limited -7.18 Million AUD 50.752%
Proteomics International Laboratories Limited -7.23 Million AUD 51.06%
Cynata Therapeutics Limited -8.8 Million AUD 59.819%
CSL Limited 5.64 Billion AUD 100.063%
Arovella Therapeutics Limited -7.19 Million AUD 50.798%
Bio-Gene Technology Limited -3.06 Million AUD -15.565%
Clinuvel Pharmaceuticals Limited 49.14 Million AUD 107.201%
Starpharma Holdings Limited -15.15 Million AUD 76.653%
Nanollose Limited -1.24 Million AUD -183.172%
Memphasys Limited -2.7 Million AUD -30.886%
Invex Therapeutics Ltd -2.13 Million AUD -65.875%
NeuroScientific Biopharmaceuticals Limited -2.05 Million AUD -72.091%
Amplia Therapeutics Limited -4.42 Million AUD 20.019%
Botanix Pharmaceuticals Limited -14.69 Million AUD 75.924%
Island Pharmaceuticals Limited -2.87 Million AUD -23.153%
Race Oncology Limited -13.38 Million AUD 73.55%
Nyrada Inc. -4.56 Million AUD 22.393%
Telix Pharmaceuticals Limited - AUD Infinity%
Dimerix Limited -25.05 Million AUD 85.877%
PharmAust Limited -6.65 Million AUD 46.849%
Immutep Limited -44.93 Million AUD 92.124%
Clarity Pharmaceuticals Ltd -44.8 Million AUD 92.1%
Alterity Therapeutics Limited -19.6 Million AUD 81.945%
BTC Health Limited 1.05 Million AUD 435.373%
Acrux Limited -9.83 Million AUD 64.011%
Neuren Pharmaceuticals Limited 225.96 Million AUD 101.566%
Biotron Limited -5.15 Million AUD 31.294%
Tissue Repair Ltd -4.87 Million AUD 27.416%
AdAlta Limited -5.26 Million AUD 32.736%
Radiopharm Theranostics Limited -47.2 Million AUD 92.503%
Hexima Limited -1 Million AUD -250.845%
AnteoTech Limited -11.72 Million AUD 69.819%
Paradigm Biopharmaceuticals Limited -65.11 Million AUD 94.565%
Recce Pharmaceuticals Ltd -22.05 Million AUD 83.95%
Avecho Biotechnology Limited -4.58 Million AUD 22.881%
Actinogen Medical Limited -12.83 Million AUD 72.434%
Immuron Limited -5.8 Million AUD 38.992%
Argenica Therapeutics Limited -5.67 Million AUD 37.594%